• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BWX
Click for more information
0.00% $4.95

BWX LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BWX
Ann: Change of Director's Interest Notice 		13/03/19 5 3.9K
13/03/19 Last post  thunderhead1 Comments Created with Sketch.  5  Views Created with Sketch.  3.9K 
BWX
Ann: Change of Director's Interest Notice 		07/03/19 1 647
07/03/19 Last post  avagadro Comments Created with Sketch.  1  Views Created with Sketch.  647 
BWX
BWX is a screaming buy from here
2
04/03/19 109 49K
04/03/19 Last post  avagadro Comments Created with Sketch.  109  Views Created with Sketch.  49K 
BWX
bwx chart
2
01/03/19 116 45K
01/03/19 Last post  avagadro Comments Created with Sketch.  116  Views Created with Sketch.  45K 
BWX
Ann: Investor presentation - 1H FY19 		22/02/19 6 1.8K
22/02/19 Last post  avagadro Comments Created with Sketch.  6  Views Created with Sketch.  1.8K 
BWX
Ann: BWX 1H19 Results Conference Call Details 		22/02/19 6 2.1K
22/02/19 Last post  avagadro Comments Created with Sketch.  6  Views Created with Sketch.  2.1K 
BWX
Ann: 1H FY19 Media Release 		22/02/19 20 5.0K
22/02/19 Last post  Nige456 Comments Created with Sketch.  20  Views Created with Sketch.  5.0K 
BWX
News: BWX BWX Ltd Updates FY19 Underlying EBITDA Guidance To $27 Mln-$29 Mln 		22/02/19 0 202
22/02/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  202 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.